← Leaderboards
Andrew G Hadd
Ambion Diagnostics, Inc.
$1,587,134
Attributed
$1,587,134
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $687K · FY2009–11$1M$750K$500K$250K$0
'09
'10
'11
Funding mix
By agency
NIH$1,587,134 · 2
By mechanism
R44$1,172,941 · 1
R43$414,193 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Follow-Up”
- Jeffrey P Krischer · University Of South Florida$398,381,597
- James Dennis Neaton · Northwestern University$283,212,546
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S Hochman · New York University School Of Medicine$125,409,158
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$119,981,780
- David R. Weir · University Of Michigan At Ann Arbor$119,885,186
Research focus
Follow-UpGuanineEarly IdentificationFmr1 GeneFragile X Mental Retardation ProteinFxtasDiagnosticEarly DiagnosisFemaleFmr1Autism Spectrum DisorderClinical TrialsAllelesFragile X SyndromeBaseCostAffectCytosine5&AposEarly TreatmentChromosomesDetectionDiagnosisGuidelines
Grant awards (3)
Amplification Strategies for Detection of Fragile X Gene Trinucleotide Repeats$485,894
R44 · FY2011 · HD · contact PI
Amplification Strategies for Detection of Fragile X Gene Trinucleotide Repeats$687,047
R44 · FY2010 · HD · contact PI
Amplification Strategies for Detection of Fragile X Trinucleotide Repeats$414,193
R43 · FY2009 · HD · contact PI